ICCC
Price
$5.50
Change
-$0.00 (-0.00%)
Updated
Apr 28 closing price
Capitalization
49.47M
15 days until earnings call
IMMP
Price
$1.65
Change
+$0.02 (+1.23%)
Updated
Apr 28 closing price
Capitalization
242.48M
29 days until earnings call
Ad is loading...

ICCC vs IMMP

Header iconICCC vs IMMP Comparison
Open Charts ICCC vs IMMPBanner chart's image
ImmuCell
Price$5.50
Change-$0.00 (-0.00%)
Volume$14.36K
Capitalization49.47M
Immutep
Price$1.65
Change+$0.02 (+1.23%)
Volume$26.97K
Capitalization242.48M
ICCC vs IMMP Comparison Chart
Loading...
ICCC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IMMP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ICCC vs. IMMP commentary
Apr 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ICCC is a Buy and IMMP is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Apr 29, 2025
Stock price -- (ICCC: $5.50 vs. IMMP: $1.65)
Brand notoriety: ICCC and IMMP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ICCC: 62% vs. IMMP: 35%
Market capitalization -- ICCC: $49.47M vs. IMMP: $242.48M
ICCC [@Biotechnology] is valued at $49.47M. IMMP’s [@Biotechnology] market capitalization is $242.48M. The market cap for tickers in the [@Biotechnology] industry ranges from $272.64B to $0. The average market capitalization across the [@Biotechnology] industry is $2.15B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ICCC’s FA Score shows that 0 FA rating(s) are green whileIMMP’s FA Score has 0 green FA rating(s).

  • ICCC’s FA Score: 0 green, 5 red.
  • IMMP’s FA Score: 0 green, 5 red.
According to our system of comparison, ICCC is a better buy in the long-term than IMMP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ICCC’s TA Score shows that 6 TA indicator(s) are bullish while IMMP’s TA Score has 4 bullish TA indicator(s).

  • ICCC’s TA Score: 6 bullish, 3 bearish.
  • IMMP’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, ICCC is a better buy in the short-term than IMMP.

Price Growth

ICCC (@Biotechnology) experienced а +2.23% price change this week, while IMMP (@Biotechnology) price change was +9.27% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.96%. For the same industry, the average monthly price growth was -1.16%, and the average quarterly price growth was -9.88%.

Reported Earning Dates

ICCC is expected to report earnings on May 14, 2025.

IMMP is expected to report earnings on Aug 27, 2025.

Industries' Descriptions

@Biotechnology (+7.96% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IMMP($242M) has a higher market cap than ICCC($49.5M). ICCC YTD gains are higher at: 6.796 vs. IMMP (-23.963). ICCC has higher annual earnings (EBITDA): -551.81K vs. IMMP (-43.83M). IMMP has more cash in the bank: 159M vs. ICCC (3.81M). IMMP has less debt than ICCC: IMMP (1.69M) vs ICCC (15.5M). ICCC has higher revenues than IMMP: ICCC (23.8M) vs IMMP (0).
ICCCIMMPICCC / IMMP
Capitalization49.5M242M20%
EBITDA-551.81K-43.83M1%
Gain YTD6.796-23.963-28%
P/E RatioN/AN/A-
Revenue23.8M0-
Total Cash3.81M159M2%
Total Debt15.5M1.69M920%
FUNDAMENTALS RATINGS
ICCC vs IMMP: Fundamental Ratings
ICCC
IMMP
OUTLOOK RATING
1..100
342
VALUATION
overvalued / fair valued / undervalued
1..100
88
Overvalued
84
Overvalued
PROFIT vs RISK RATING
1..100
8477
SMR RATING
1..100
9293
PRICE GROWTH RATING
1..100
3981
P/E GROWTH RATING
1..100
99100
SEASONALITY SCORE
1..100
n/a35

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

IMMP's Valuation (84) in the Biotechnology industry is in the same range as ICCC (88) in the Medical Specialties industry. This means that IMMP’s stock grew similarly to ICCC’s over the last 12 months.

IMMP's Profit vs Risk Rating (77) in the Biotechnology industry is in the same range as ICCC (84) in the Medical Specialties industry. This means that IMMP’s stock grew similarly to ICCC’s over the last 12 months.

ICCC's SMR Rating (92) in the Medical Specialties industry is in the same range as IMMP (93) in the Biotechnology industry. This means that ICCC’s stock grew similarly to IMMP’s over the last 12 months.

ICCC's Price Growth Rating (39) in the Medical Specialties industry is somewhat better than the same rating for IMMP (81) in the Biotechnology industry. This means that ICCC’s stock grew somewhat faster than IMMP’s over the last 12 months.

ICCC's P/E Growth Rating (99) in the Medical Specialties industry is in the same range as IMMP (100) in the Biotechnology industry. This means that ICCC’s stock grew similarly to IMMP’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ICCCIMMP
RSI
ODDS (%)
N/A
Bullish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
82%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
81%
MACD
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
83%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
72%
Bearish Trend 1 day ago
80%
Advances
ODDS (%)
Bullish Trend 7 days ago
77%
Bullish Trend 6 days ago
85%
Declines
ODDS (%)
Bearish Trend 26 days ago
75%
Bearish Trend 23 days ago
82%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
75%
Bearish Trend 7 days ago
86%
View a ticker or compare two or three
Ad is loading...
ICCC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IMMP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CGWRX62.46N/A
N/A
Columbia Large Cap Growth R
MRJSX10.63N/A
N/A
Morgan Stanley Multi-Asset Real ReturnR6
WFSAX24.03N/A
N/A
Allspring Small Company Growth A
MSAAX17.58N/A
N/A
Morgan Stanley Inst Passport ovrs eq C
PKAPX12.36N/A
N/A
PIMCO RAE US I-2

ICCC and

Correlation & Price change

A.I.dvisor indicates that over the last year, ICCC has been loosely correlated with NKTX. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if ICCC jumps, then NKTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ICCC
1D Price
Change %
ICCC100%
N/A
NKTX - ICCC
43%
Loosely correlated
-4.74%
ATHE - ICCC
27%
Poorly correlated
-0.02%
BOLT - ICCC
26%
Poorly correlated
-5.08%
IMMP - ICCC
23%
Poorly correlated
+1.23%
MYNDF - ICCC
23%
Poorly correlated
N/A
More

IMMP and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMMP has been loosely correlated with PRRUF. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if IMMP jumps, then PRRUF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMMP
1D Price
Change %
IMMP100%
+1.23%
PRRUF - IMMP
43%
Loosely correlated
N/A
CALC - IMMP
39%
Loosely correlated
+0.67%
XFOR - IMMP
37%
Loosely correlated
-6.40%
ARCT - IMMP
31%
Poorly correlated
-0.70%
AXON - IMMP
31%
Poorly correlated
-0.22%
More